ATR-IN-9

ATR-IN-9

• CAS Number: 2417513-43-8
• UNSPSC Description: ATR-IN-9 is a potent inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR) extracted from patent WO2020087170A1, compound 59, has an IC50 of 10 nM[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/atr-in-9.html
• Solubility: 10 mM in DMSO
• Smiles: OC1(CCC(C)(CC1)C#N)C2=C3C(N(C4=NNC=C4)N=C3)=NC(N5[C@@H](COCC5)C)=C2
• Molecular Weight: 421.50
• References & Citations: [1]Crane SN, et, al. Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors. WO2020087170A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported